INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 410m ago
HOUSE PTR9m ago
SEC 13F9m ago
ROBINHOOD CHAIN9m ago
SEC FORM 4/Option exerciseVerified data

Poe Brandon reported BSEM

Chief Financial Officer · BioStem Technologies, Inc. · BioStem Technologies, Inc. — Restricted Stock Units

Side
M
Value
—
Shares
10.6K
Price
—
Executed
Aug 11, 2026
Disclosed
Aug 20, 2026
Disclosure timeline9 days from execution to publication · legal deadline 2 business days
Aug 11 executedAug 20, 2026 disclosed

BSEM · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
31/ 100 · ELEVATED
Methodology →
  • Transaction type0 / 20

    Option exercise — administrative, little informational value

  • Relative size+13 / 25

No reported dollar value · 97.1% of prior position

  • Filing timing+10 / 15

    Disclosed 7 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · BSEM

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    21
    UJ
    Ungrodt JodiDirector
    BSEMBioStem Technologies, Inc.
    Option exercise
    		M—
    5,647 sh
    		Aug 27, 2026Aug 28, 2026
    traded Aug 27, 2026
    		+1dSEC FORM 4

    Evidence

    9
    UJ
    Ungrodt JodiDirector
    BSEMBioStem Technologies, Inc.
    Option exercise
    		M—
    5,647 sh
    		Aug 27, 2026Aug 28, 2026
    traded Aug 27, 2026
    		+1dSEC FORM 4

    Evidence

    9
    SD
    Sonenreich Steven DDirector
    BSEMBioStem Technologies, Inc.
    Option exercise
    		M—
    7,671 sh
    		Aug 27, 2026Aug 28, 2026
    traded Aug 27, 2026
    		+1dSEC FORM 4

    Evidence

    9
    SD
    Sonenreich Steven DDirector
    BSEMBioStem Technologies, Inc.
    Option exercise
    		M—
    7,671 sh
    		Aug 27, 2026Aug 28, 2026
    traded Aug 27, 2026
    		+1dSEC FORM 4

    Evidence

    13
    WH
    Warrington Kenneth Howard JrDirector
    BSEMBioStem Technologies, Inc.
    Option exercise
    		M—
    5,094 sh
    		Aug 27, 2026Aug 28, 2026
    traded Aug 27, 2026
    		+1dSEC FORM 4

    Evidence

    9
    WH
    Warrington Kenneth Howard JrDirector
    BSEMBioStem Technologies, Inc.
    Option exercise
    		M—
    5,094 sh
    		Aug 27, 2026Aug 28, 2026
    traded Aug 27, 2026
    		+1dSEC FORM 4

    Evidence

    9
    LR
    Lesser Hannaway RaynaDirector
    BSEMBioStem Technologies, Inc.
    Option exercise
    		M—
    7,671 sh
    		Aug 27, 2026Aug 28, 2026
    traded Aug 27, 2026
    		+1dSEC FORM 4

    Evidence

    9
    LR
    Lesser Hannaway RaynaDirector
    BSEMBioStem Technologies, Inc.
    Option exercise
    		M—
    7,671 sh
    		Aug 27, 2026Aug 28, 2026
    traded Aug 27, 2026
    		+1dSEC FORM 4

    Evidence

    19
    FA
    Fortunato Michael AChief Accounting Officer
    BSEMBioStem Technologies, Inc.
    Option exercise
    		M—
    970 sh
    		Aug 9, 2026Aug 20, 2026
    traded Aug 9, 2026
    		+11dSEC FORM 4

    Evidence

    23
    FA
    Fortunato Michael AChief Accounting Officer
    BSEMBioStem Technologies, Inc.
    Option exercise
    		M—
    970 sh
    		Aug 9, 2026Aug 20, 2026
    traded Aug 9, 2026
    		+11dSEC FORM 4

    Evidence

    27
    PB
    Poe BrandonChief Financial Officer
    BSEMBioStem Technologies, Inc.
    Option exercise
    		M—
    10.6K sh
    		Aug 11, 2026Aug 20, 2026
    traded Aug 11, 2026
    		+9dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002147189-26-000006
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Aug 11, 2026
    Published
    Aug 20, 2026
    Ingested by INSIDER
    Nov 5, 02:21 UTC
    Last re-read
    Nov 5, 02:21 UTC

    Extracted facts

    Filer
    Poe Brandon
    Role
    Chief Financial Officer
    Transaction
    Option exerciseAs filed: “M”
    Asset
    BioStem Technologies, Inc. — Restricted Stock Units
    Ticker
    BSEM
    Shares
    10.6K
    Price per share
    $0
    Execution date (reported)
    Aug 11, 2026
    Owned after transaction
    21.6K shares
    Days from execution to publication
    9

    What this establishes

    Poe Brandon filed this Form 4 reporting a option exercise of BSEM on Aug 11, 2026. It became public on Aug 20, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Chief Financial Officer
    Poe Brandoncik:0002147189
    Issuer
    BioStem Technologies, Inc.cik:0001658678

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.